Spelman, T. Et Al. 2015. Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity. 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , (Barcelona, Spain), 237-238.

Spelman, T., Izquierdo, G., Alroughani, R., Fernandez Bolaos, R., Havrdova, E., Horaova, D., ... Oreja-Guevara, C.(2015). Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity . 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) (pp.237-238). Barcelona, Spain

Spelman, T. Et Al. "Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity," 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Barcelona, Spain, 2015

Spelman, T. Et Al. "Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity." 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , Barcelona, Spain, pp.237-238, 2015

Spelman, T. Et Al. (2015) . "Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity." 31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS) , Barcelona, Spain, pp.237-238.

@conferencepaper{conferencepaper, author={T. Spelman Et Al. }, title={Comparison of efficacy and persistence of first line fingolimod vs interferon-beta/glatiramer in the presence of prior disease activity}, congress name={31st Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS)}, city={Barcelona}, country={Spain}, year={2015}, pages={237-238} }